Quick Links

Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid Development

Release Date: September 29, 2017
Expiration Date: September 29, 2018
Media: Internet - based


Activity Overview

This online activity features an expert panel discussion of key data in lung cancer immunotherapy, including practice-changing data and commentary on the optimal duration of therapy, combination regimens, biomarkers, and the management of immune-related adverse events. Throughout the program, the experts provide their perspectives on the clinical application of these data and the future direction of immunotherapies within the lung cancer treatment landscape.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

CME Table of Contents

  • Introduction
  • Key Randomized Data With Immunotherapy in Lung Cancer
  • What is the Optimal Duration of Therapy?
  • Dual Immunotherapy Combinations
  • Emerging Perspectives on Biomarkers
  • Managing Immune-Related Adverse Events

Requirements for Successful Completion

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video” will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Target Audience

This educational activity is directed oncologists interested in the treatment of lung cancer. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with lung cancer are also invited to participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Describe the mechanistic rationale for single agent and combination immunotherapeutic strategies in the management of advanced non–small cell lung cancer (NSCLC)
  • Evaluate findings from recent trials in the context of evolving immunotherapy treatment paradigms for patients with advanced NSCLC
  • Explain emerging perspectives on the use of biomarkers as a method to personalize care with the use of immunotherapeutic strategies
  • Apply best practices to proactively manage and mitigate the impact of treatment-related toxicities with the use of evolving immunotherapeutic combination approaches

Faculty, Staff, and Planners' Disclosures


Naiyer Rizvi, MD
Professor of Medicine
Director, Thoracic Oncology
Co-Director, Cancer Immunotherapy Program
Price Chair, Clinical Translational Research
Columbia University Medical Center
New York, NY

Disclosure: Consultant: Lilly, Bristol-Myers Squibb; Stock/Shareholder: Gritstone Oncology, ARMO Biosciences; Honoraria and/or Advisory Board: Roche, AztraZeneca, Novartis, Merck, and Pfizer.


Leena Gandhi, MD, PhD
Director of Thoracic Medical Oncology
Associate Professor of Medicine
NYU Perlmutter Cancer Center
NYU Langone Medical Center
New York, NY

Disclosure: Disclosure: Consultant: SAB, Genentech, Merck, and Ignyta.

Justin F. Gainor, MD
Assistant Professor
Harvard Medical School
Assistant in Medicine
Massachusetts General Hospital
Boston, MA

Disclosure: Consultant: Pfizer, Bristol-Myers Squibb, Novartis, Genentech/Roche, Incyte, Ariad, and Merck.

Dr. Hossein Borghaei, DO, MS
Chief, Thoracic Medical Oncology
Fox Chase Cancer Center
Philadelphia, PA

Disclosure: Grant/Research Support: Millennium, Merck, Celgene; Consultant: Bristol-Myers Squibb, EMD Serono Inc., Lilly, Merck, Pfizer, Novartis, AstraZeneca, G-mab, Celgene, B.I., and Genentech.

The staff of Physicians' Education Resource®, LLC have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any of the companies that provided commercial support for this activity.

CME Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive, Suite 110
Cranbury, NJ 08512
Toll Free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Become a Member

Forgot Password?
Filter By